// App-Quantinova.ai

OA19.01 : Prospective Study of Lung Cancer Screening Criteria: USPSTF2013 vs PLCOm2012 – International Lung Screening Trial (ILST) Results

Researchers

Presenter

  • M. Tammemagi

Principal Investigators

  • R. Myers

  • M. Ruparel

  • A. Tremblay

  • S. Atkar-Khattra

  • H. Marshall

  • F. Brims

  • P. Fogarty

  • E. Stone

  • A. Rosell

  • M. Weber

  • J. Yee

  • J. Mayo

  • C. Berg

  • D. Lam

  • S. Janes

  • K. Fong

  • S. Lam

Medical Centers

  • Fiona Stanley Hospital, Perth/AU

  • The Daffodil Centre, Sydney/AU

  • Radiology, Vancouver General Hospital, Vancouver/CA

  • St Vincent'S Private Hospital Northside, Brisbane/AU

  • Sir Charles Gairdner Hospita, Nedlands/AU

  • Thoracic Surgery, Vancouver General Hospital, Vancouver/CA

  • Nci, Bethesda/MD/US

  • Epworth Internal Medicine Clinical Institute, Melbourne/AU

  • Curtin University, Perth/AU

  • St Vincent'S Clinic, Sydney/ACT/AU

  • Prince Charles Hospital Northside Clinical Unit, Brisbane/AU

  • University Hospital Germans Trias i Pujol-ICO, Barcelona, Spain

  • Royal Melbourne Hospital,, Melbourne/AU

  • University of Hong Kong, Hong Kong, China

  • University of Calgary, Calgary

  • Integrative Oncology, BC Cancer, Vancouver, BC, Canada.

  • University of Sydney, Sydney/AU

  • University College London, London, UK

  • Health Sciences, Brock University, St. Catharines, Canada

Locations

  • United Kingdom

  • Canada

  • United States

  • Australia

  • Venezuela

  • Hong Kong

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Lung Cancer

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multinational

  • Prospective

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved